1st longer term tirzepatide study (3 years)
Docs Who Lift
Intro
This chapter delves into the speakers' reflections on the Obesity Week conference, emphasizing groundbreaking research on tirzepatide. They specifically discuss the importance of long-term data from surmount trials and the ongoing debates about the roles of resistance versus aerobic training in relation to new obesity treatments.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
